Response to the letter to the editor regarding "Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy".

Saved in:
Bibliographic Details
Title: Response to the letter to the editor regarding "Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy".
Authors: Hung YH; Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Internal Medicine, Division of Cardiology, National Taiwan University Hospital, Taipei, Taiwan., Cheng MF; Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: meifang@ntuh.gov.tw., Chao CC; Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: ccchao@ntu.edu.tw., Lin YH; Department of Internal Medicine, Division of Cardiology, National Taiwan University Hospital, Taipei, Taiwan.
Source: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16.
Publication Type: Letter
Journal Info: Publisher: Formosan Medical Association, Elsevier Country of Publication: Singapore NLM ID: 9214933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0929-6646 (Print) Linking ISSN: 09296646 NLM ISO Abbreviation: J Formos Med Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0929-6646
DOI:10.1016/j.jfma.2026.06.017